Jackson, Grant Investment Advisers, Inc. Astrazeneca PLC Transaction History
Jackson, Grant Investment Advisers, Inc.
- $257 Million
- Q4 2024
A detailed history of Jackson, Grant Investment Advisers, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Jackson, Grant Investment Advisers, Inc. holds 264 shares of AZN stock, worth $20,581. This represents 0.01% of its overall portfolio holdings.
Number of Shares
264
Previous 264
-0.0%
Holding current value
$20,581
Previous $20,000
15.0%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,365Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.71 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.2 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.92 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.89 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.87 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...